GW Pharmaceutical

Shares of GW Pharmaceuticals PLC (NASDAQ: GWPH) were trading higher by more than 17 percent Monday, but analysts at Cantor Fitzgerald believe the surge has just begun. GW Pharma announced a second successful pivotal trial in an ongoing Phase 3 trial which explores Epidiolex, its lead...